Sanara MedTech Inc. Announces Pricing of Public Offering
FORT WORTH, TX / ACCESSWIRE / February 12, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech...
Year: 2021
CureVac Initiates Rolling Submission With European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV
Rolling submission with EMA initiated to accelerate time to potential marketing authorization of CVnCoV Submission of CVnCoV pre-clinical data package...
Preventing And Appealing Clinical Denials With Analytics, Automation, And AI
By HGS Healthcare U.S. hospitals lose $262 billion due to denied claims each year, representing roughly 10% of the total claims paid....
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
BURLINGAME, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced the pricing...
Quotient Limited Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
JERSEY, Channel Islands, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company),...
Cronos Group Inc. to Hold 2020 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2021
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will...
Jushi Holdings Inc. Announces Closing of Offering of Subordinate Voting Shares
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BOCA RATON, Fla., Feb. 12,...
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public...
Vistin Pharma ASA: Invitation to Q4 2020 conference call
Oslo, Norway, 12 February 2020 Vistin Pharma ASA will release its fourth quarter 2020 results on Friday 19th of February 2021....
Vericel Announces Termination of Shareholder Rights Agreement
CAMBRIDGE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
U.S. government exercises option to bring total supply to 300 million doses, enabling vaccinations for 150 million people NEW YORK...
Assure to Attend Upcoming Investor Conferences
DENVER, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider...
Milestone Scientific to Participate in the Winter Wonderland Conference- Best Ideas from the Buy-Side
ROSELAND, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug instruments...
George Archos Reports Holdings in Verano Holdings Corp.
TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) -- George Archos (the “Acquiror”), the Chairman, CEO and a director of Verano Holdings...
Avricore Health Completes $1.54 Million Financing and Grants Options
VANCOUVER, British Columbia, Feb. 12, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces it...
Smile Direct Club to Report Fourth Quarter and Year End 2020 Results on March 4, 2021
NASHVILLE, Tenn., Feb. 12, 2021 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the...
Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
BASKING RIDGE, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage...
Jounce Therapeutics Appoints Luisa Salter-Cid, Ph.D., to its Board of Directors
CAMBRIDGE, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
BridgeBio Pharma, Inc. Announces Pricing of Secondary Offering of Common Stock
PALO ALTO, Calif. , Feb. 12, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”)...
Denali Therapeutics Reports Positive Three-Month Data from Phase 1/2 Study with ETV:IDS (DNL310) in Patients with Hunter Syndrome (MPS II)
Sustained normalization and further decreased levels of CSF glycosaminoglycan heparan sulfate, a key CNS disease biomarker, observed after three months...